featured
Effectiveness of Ocrelizumab in Patients With Primary Progressive MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurotherapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
Neurotherapeutics 2023 Aug 23;[EPub Ahead of Print], CG Chisari, A Bianco, V Brescia Morra, M Calabrese, F Capone, P Cavalla, C Chiavazza, C Comi, M Danni, M Filippi, P Iaffaldano, R Lanzillo, S Lo Fermo, A Lucisano, A Lugaresi, G Lus, GA Marfia, F Marinelli, M Mirabella, L Moiola, C Perin, S Realmuto, S Toscano, M Trojano, D Vecchio, F PattiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.